small cell lung cancerBackground: small cell lung cancer (SCLC) is a leading cause of death all over the world. Diagnostic and therapeutic arsenals have improved in recent years, but we are unsure as to whether these advances have been transferred to clinical practice. The aim of this study...
Small-celllung cancer(SCLC) is a disease in which cells in your lung begin growing out of control. It starts in nerve cells or cells that make hormones. About 10% to 15% of lung cancer cases are small-cell. The other kind is called non-small-cell lung cancer. They’re different in ...
Small-cell lung cancer grows rapidly. The time from the development of symptoms of SCLC to diagnosis is usually 90 days or less. Small-cell lung cancer spreads quickly. From 67%-75% of people who develop small cell lung cancerwill have spread the SCLC outside of the lung to other parts ...
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer Traditionally, patients with small-cell lung cancer (SCLC), a malignancy with a dismal prognosis, have had limited treatment options. Over the past few years, advances in the molecular characterization of...
The main forms of lung cancer include small cell lung cancer (SCLC) [3] and non-small cell lung cancer (NSCLC) [2]. Small cell lung cancer is an aggressive disease that accounts for 10–15% of all lung cancers. Metastases to regional lymph nodes or distant sites is present in ...
Small-cell lung cancer is an aggressive form of lung cancer and has been difficult to treat due to therapy resistance. This Review discusses challenges and recent advances in uncovering molecular changes that allow potentially efficient therapies. Small-
Small-cell carcinoma (oat cell cancer) Combined small-cell carcinoma Both include many types of cells that grow and spread in different ways. They’re named according to what the cells look like under a microscope. Small-cell lung cancer differs from non-small-cell lung cancer in some key ...
Small cell lung cancer is a highly malignant tumor. Its biological behavior is bad and its prognosis is very dangerous. Compared with the same range of dissemination, small cell lung cancer is shorter than other types of lung cancer before diagnosis, and the survival time after diagnosis is ...
Figure 2. Phase II and III trials assessing an immune-chemotherapy strategy in the first-line setting in extensive-disease (ED) small cell lung cancer (SCLC) with outcomes. CI, confidence interval; CR, complete response; PR, partial response; CT, chemotherapy; HR, hazard ratio; OS, overall...
Prognosis of Small Cell Lung Cancer 来自 Springer 喜欢 0 阅读量: 29 作者: M Paesmans 展开 摘要: Prognostic factors are defined as the pre-therapeutic factors characterizing a patient (or his/her disease) that are related to clinical outcomes of the disease. Ideally, using prognostic ...